NO151155C - Analogifremgangsmaate for fremstilling av terapeutisk virksomme spirobenzofuranonforbindelser - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk virksomme spirobenzofuranonforbindelser

Info

Publication number
NO151155C
NO151155C NO78784367A NO784367A NO151155C NO 151155 C NO151155 C NO 151155C NO 78784367 A NO78784367 A NO 78784367A NO 784367 A NO784367 A NO 784367A NO 151155 C NO151155 C NO 151155C
Authority
NO
Norway
Prior art keywords
spirobenzofuranon
compounds
preparation
therapeutically effective
analogy procedure
Prior art date
Application number
NO78784367A
Other languages
English (en)
Other versions
NO151155B (no
NO784367L (no
Inventor
Hirosada Sugihara
Masazumi Watanabe
Mitsuru Kawada
Isuke Imada
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP15917777A external-priority patent/JPS5498752A/ja
Priority claimed from JP7470078A external-priority patent/JPS552623A/ja
Priority claimed from JP13696778A external-priority patent/JPS5564582A/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO784367L publication Critical patent/NO784367L/no
Publication of NO151155B publication Critical patent/NO151155B/no
Publication of NO151155C publication Critical patent/NO151155C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO78784367A 1977-12-27 1978-12-22 Analogifremgangsmaate for fremstilling av terapeutisk virksomme spirobenzofuranonforbindelser NO151155C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP15917777A JPS5498752A (en) 1977-12-27 1977-12-27 Spiro compound and its preparation
JP7470078A JPS552623A (en) 1978-06-19 1978-06-19 Spiro compound and its preparation
JP13696778A JPS5564582A (en) 1978-11-06 1978-11-06 Spiro compound and its preparation

Publications (3)

Publication Number Publication Date
NO784367L NO784367L (no) 1979-06-28
NO151155B NO151155B (no) 1984-11-12
NO151155C true NO151155C (no) 1985-02-20

Family

ID=27301589

Family Applications (1)

Application Number Title Priority Date Filing Date
NO78784367A NO151155C (no) 1977-12-27 1978-12-22 Analogifremgangsmaate for fremstilling av terapeutisk virksomme spirobenzofuranonforbindelser

Country Status (12)

Country Link
EP (1) EP0003084B1 (no)
AT (1) AT372954B (no)
AU (1) AU521851B2 (no)
CA (1) CA1113467A (no)
DE (1) DE2861651D1 (no)
DK (1) DK149891C (no)
ES (2) ES476330A1 (no)
HK (1) HK6285A (no)
HU (1) HU179601B (no)
NO (1) NO151155C (no)
SG (1) SG83884G (no)
SU (1) SU1044225A3 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR66729B (no) * 1979-05-04 1981-04-17 Takeda Chemical Industries Ltd
CA2589363A1 (en) 2004-12-13 2006-06-22 Eli Lilly And Company Spiro derivatives as lipoxygenase inhibitors

Also Published As

Publication number Publication date
AU4287078A (en) 1979-07-05
ATA928478A (de) 1983-04-15
EP0003084B1 (en) 1982-02-24
AU521851B2 (en) 1982-05-06
ES488332A0 (es) 1980-12-16
ES476330A1 (es) 1981-12-16
NO151155B (no) 1984-11-12
AT372954B (de) 1983-12-12
SG83884G (en) 1985-04-26
HK6285A (en) 1985-02-01
NO784367L (no) 1979-06-28
SU1044225A3 (ru) 1983-09-23
DE2861651D1 (en) 1982-03-25
HU179601B (en) 1982-11-29
CA1113467A (en) 1981-12-01
DK149891C (da) 1987-06-15
ES8102114A1 (es) 1980-12-16
DK149891B (da) 1986-10-20
DK574078A (da) 1979-06-28
EP0003084A1 (en) 1979-07-25

Similar Documents

Publication Publication Date Title
NO781082L (no) Fremgangsmaate ved fremstilling av jodofore forbindelser
NO149662C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive c-076-forbindelser
NO149174C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk virksomme tiazinderivater
NO147025C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme pyridinyl-2(1h)-pyridinoner
NO150800C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tricykliske forbindelser
NO148281C (no) Fremgangsmaate ved fremstilling av allergenholdige forbindelser
NO147950C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminoalkyl-heterocykliske forbindelser
NO154522C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme kinolinderivater.
NO152651C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 0-substituerte derivater av (+)-cyanidan-3-ol
NO147562C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme xantinderivater
NO782484L (no) Fremgangsmaate for fremstilling av sulfobetainer
NO145307C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk virksomme nucleosider
NO147953C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive antracyklinglukosider
NO143796C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme piperazinyliminorifamyciner
NO773682L (no) Fremgangsmaate ved fremstilling av furocumariner
NO151201C (no) Fremgangsmaate for fremstilling av terapeutisk virksomme antigenderivater
NO152255C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolylvinylethere
NO145762C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antracyklinglykosidiske forbindelser
NO150081C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme derivater av perhydro-aza-heterocykler
NO149313C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO149037C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner
NO146022C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme benzofenonderivater
NO148454C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater
NO145095C (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme polyenforbindelser
NO151196C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme fluorerte alkenylendiaminderivater